Board Meeting Intimation for THE MEETING OF BOARD OF DIRECTORS AS ON MONDAY, 13TH AUGUST, 2018
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve THE MEETING OF BOARD OF DIRECTORS OF THE COMPANY IS SCHEDULED TO BE HELD ON MONDAY, 13TH AUGUST, 2018 TO CONSIDER AND APPROVE THE UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30TH, 2018 AND TO CONSIDER OTHER MATTERS. Shareholding for the Period Ended June 30, 2018
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Mukund MehtaDesignation :- Director Appointment Of Director.
The Board of Directors of the Company at its meeting held on today i.e.June 28, 2018 have approved appointment of Mr. Venkita Subramanian Rajan as an Additional Non- Executive Independent Director of the Company w.e.f. June 28, 2018. Board Meeting As On 28Th June, 2018
We wish to inform you that a meeting of the Board of Directors of Kilitch Drugs (India) Limited will be held on Thursday, the 28th day of June, 2018, at 4.00 p.m.to consider appointment of Shri Venkita Subramanian Rajan (DIN:00059146) as an Additional Director. Board recommends Dividend
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2018, in alia , has recommended a final dividend of Re. 0.50 per Equity Share ( Face Value of Re. 10/- each) for the year ended 31st March, 2018. This dividend upon approval by the shareholders at the ensuing Annual General Meeting (AGM) will be paid within 30 days from the date of AGM. Board Meeting-Outcome of Board Meeting
We enclose herewith the audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March, 2018, which have been approved and taken on record at the meeting of the Board of Directors of the Company held today, the 25th May, 2018. Further, we would like to inform you that the Board of Directors have recommended a final dividend of Re. 0.50 per Equity Share (face value of Re. 10/- each) for the... Board to consider Dividend
With reference to the earlier letter dated May 17, 2018, Kilitch Drugs India Ltd has now informed BSE that the Board ofDirectors may consider declaration/recommendation of Dividend at their meeting scheduled to be held on May 25, 2018.